Immune processes at the level of the nephron. The immune system and its compartmentalization

Central-European Journal of Immunology

Volumn 34, Issue 3, 2009, Pages 192-206

  Gluhovschi, Gheorghe ^a   Gluhovschi, Cristina ^a   Bob, Flaviu ^a   Velciov, Silvia ^a   Trandafirescu, Virginia ^a   Petrica, Ligia ^a   Bozdog, Gheorghe ^a   Cioca, Daniel ^b  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Immunophysiology and Biotechnology Center   (Romania)

Author keywords

Glomerulonephritis; Tubulo interstitial disease; Vascular disease

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CHEMOKINE; COMPLEMENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; T LYMPHOCYTE RECEPTOR;

B LYMPHOCYTE; CELL ACTIVATION; CELL AGGREGATION; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELLULAR IMMUNITY; DENDRITIC CELL; DIGESTIVE SYSTEM; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INTERSTITIAL NEPHRITIS; JUXTAGLOMERULAR CELL; KIDNEY DISEASE; KIDNEY INTERSTITIUM; LYMPHOID ORGAN; MEMBRANOUS GLOMERULONEPHRITIS; NEPHRON; NONHUMAN; PROTEINURIA; RESPIRATORY SYSTEM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; URINARY TRACT INFECTION; VASCULAR DISEASE;

EID: 70350616138     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Crivellato E, Vacca A, Ribatti D (2004): Setting the stage: an anatomist's view of the immune system. Trends in Immunol 25: 210-217. (Pubitemid 38368168)
2. Brandtzaeg P, Farstad IN, Haraldsen G (1999): Regional specialization in the mucosal immune system: primed cells do not always come along the same track. Immunology Today 20: 267-277. (Pubitemid 29258164)
3. Becker S, Clapp WA, Quay J et al. (1999): Compartmentalization of the inflammatory response to inhaled grain dust. Am J Respir Crit Care Med 160: 1309-1318.
4. Segerer S, Schlondorff D (2008): B cells and tertiary lymphoid organs in renal inflammation. Kidney Int 73: 523-527.
5. Picker LI (1992): Mechanisms of lymphocyte homing. Curr Opin Immunol 4: 277-286.
6. Heller F, Lindenmeyer MT, Cohen CD et al. (2007): The contribution of B cells to renal interstitial inflammation. Am J Pathol 170: 457-468. (Pubitemid 47339383)
7. Steinmetz OM, Velden J, Kneissler U et al. (2008): Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int 74: 448-457.
8. Ninichuk V, Anders HJ (2008): Bone marrow-derived progenitor cells and renal fibrosis. Front Biosci 1: 5163-5173.
9. Anders HJ, Vielhauer V, Schlondorf D (2004): Current paradigms about chemokines as therapeutic targets. Nephrol Dial Transplant 19: 2948-2964. (Pubitemid 40057611)
10. Eis V, Luckow B, Vielhauer V et al. (2008): Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 1: 337-347. (Pubitemid 38140774)
11. Segerer S, Henger A, Schmid H et al. (2006): Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney Int 69: 1765-1773. (Pubitemid 43739203)
12. Tesch GH, Schwarting A, Kinoshita K et al. (1999): Monocyte chemoattractant protein-1 promotes macrophage- mediated tubular injury, but not glomerular injury in nephrotoxic serum nephritis. J Clin Invest 103: 73-80. (Pubitemid 29031165)
13. Panzer U, Steinmetz OM, Reinking RR et al. (2006): Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol 17: 454-464.
14. Woltman AM, Fijter JW, Zuidwijk K et al. (2007): Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int 71: 1001-1008. (Pubitemid 46741991)
15. Segerer S, Heller F, Lindenmeyer MT et al. (2008): Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int 74: 37-46. (Pubitemid 351841902)
16. Welch TR, Beischel LS, Witte DP (1993): Differential expression of complement C3 and C4 in the human kidney. J Clin Invest 92: 1451-1458. (Pubitemid 23273924)
17. Sheerin NS, Risley P, Abe K et al. (2008): Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB 22: 1065-1072.
18. Sheerin NS, Abe K, Risley P, Sacks SH (2006): Accumulation of immune complexes in glomerular disease is independent of locally synthesized c3. J Am Soc Nephrol 17: 686-696.
19. Sacks S, Zhou W (2009): New Boundaries for complement in renal disease. J Am Soc Nephrol doi:10.1681/ASN.2007101121.
20. De Haij S, Daha MR, van Kooten C (2004): Mechanism of steroid action in renal epithelial cells. Kidney Int 65: 1577-1588. (Pubitemid 38591004)
21. Troyanov S, Roasi DL, Pandes M et al. (2006): Renal pathology in idiopathic membranous nephropathy. A new perspective. Kidney Int 69: 1641-1648.
22. Becker GJ, Kincaid-Smith P (1993): Reflux nephropathy: the glomerular lesions and progression of renal failure. Pediatr Nephrol 7: 365
23. Tada M, Jimi S, Hisano S et al. (2001): Histopathological evidence of poor prognosis in patients with vesicoureteral reflux. Pediatr Nephrol 16: 482-487. (Pubitemid 32515146)
24. Le Hir M, Keller C, Eschmann V et al. (2001): Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 12: 2060-2071. (Pubitemid 32880342)
25. Nakatani K, Fujii H, Hasegawa H et al. (2004): Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models. Kidney Int 65: 1290-1300. (Pubitemid 38406967)
26. Tykocinski ML, Kaplan DR, Medof ME (1996): Antigen presenting cell engineering. Am J Pathol 148: 1-16.
27. Quigg RJ (2003): Why study membranous nephropathy in rats. Kidney Int 64: 2318.
28. Ali AA, Wilson E, Moorhead JF (1994): Minimal change glomerular nephritis. Normal kidneys in an abnormal environment. Transplantation 58: 849.
29. Glassock R (2003): Circulating permeability factors in the nephrotic syndrome: a fresh look at an old problem. J Am Soc Nephrol 14: 541-543.
30. Mathieson PW (2003): Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant 18 (Suppl 6): vi26- vi29.
31. Goumenos DS, Tsakas S, El Nahas AM et al. (2002): Transforming growth factor beta1 in the kidney and urine of patients with glomerular disease and proteinuria. Nephrol Dial Transplant 17: 2145-2152. (Pubitemid 35446670)
32. Glassock RJ (2003): Diagnosis and natural course of membranous nephropathy. Sem Nephrol 23: 1-10.
33. Cattran D, Neogi T, Sharma R et al. (2003): Serial estimates of serum permeability and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol 14: 440-447.
34. Belson A, Yorgin PD, Al-Uzri AY et al. (2001): Long-term plasmapheresis and protein A column treatment of recurrent FSGS. Pediatr Nephrol 16: 985-989. (Pubitemid 34026707)
35. Kriz W, Hartmann I, Hosser H et al. (2001): Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in nephrons with segmental glomerulosclerosis. J Am Soc Nephrol 12: 496-506. (Pubitemid 32180018)
36. Rangan GK, Pippin JW, Couser WG (2004): C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int 66: 1838-1848.
37. Murakami K, Takemura T, Hino S, Yoshioka K (1997): Urinary transforming growth factor-beta in patients with glomerular diseases. Pediatr Nephrol 11: 334-336. (Pubitemid 27230820)
38. Couser WG (1999): Glomerulonephritis. Lancet 353: 1509.
39. Cunningham PN, Quigg RJ (2005): Contrasting Roles of Complement Activation and Its Regulation in Membranous Nephropathy. J Am Soc Nephrol 16: 1214-1222.
40. Couser WG (2005): Membranous nephropathy: a long road but well traveled. J Am Soc Nephrol 16: 1184-1187.
41. Nangaku M, Shankland SJ, Couser WG (2005): Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 16: 1195-1204.
42. Ronco P, Debiec H (2005): Molecular pathomechanisms of membranous nephropathy: from Heyman nephritis to alloimunization. J Am Soc Nephrol 16: 1205-1213. (Pubitemid 41716505)
43. Zoja C, Donadelli R, Colleoni S et al. (1998): Protein overload stimulates RANTES production by proximal tubular cells depending on NFkB activation. Kidney Int 53: 1608-1615. (Pubitemid 28243743)
44. Morigi M, Macconi D, Zoja C et al. (2002): Protein overload-induced NF-kB activation in proximal tubular cells requires H2O2 through PKC dependent pathway. J Am Soc Nephrol 13: 1179-1189.
45. rd ed., Oxford University Press. Vol.I. Oxford 2005, pp. 389-414.
46. Zoja C, Morigi M, Remuzzi G (2003): Proteinuria and phenotypic change of proximal tubular cells. J Am Soc Nephrol 14: 36-41.
47. Wang Y, Chen J, Chen L et al. (1997): Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8: 1537-1545.
48. Eddy A (2004): Proteinuria and interstitial injury. Nephrol Dial Transplant 19: 277-281.
49. Couser WG (1990): Mediation of immune glomerular injury. J Am Soc Nephrol 1: 13-29.
50. Kamijo A, Kimura K, Sugaya T et al. (2002): Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 62: 1628-1637. (Pubitemid 35286270)
51. Pusey CD (2003): Anti-glomerular basement membrane disease. Kidney Int 64: 1535-1550.
52. Hill GS, Delahousse M, Nochy D et al. (2002): Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int 61: 2176-2186. (Pubitemid 34539335)
53. Haas M, Eustace JA (2004): Immune complex deposits in ANCA-associated crescentic glomerulonephritis: A study of 126 cases. Kidney Int 65: 2145-2152. (Pubitemid 38670000)
54. rd ed., Oxford University Press. Vol.I. Oxford 2005, pp. 559-577.
55. Jennette JC (2003): Rapidly progressive glomerulonephritis. Kidney Int 63: 1164-1177.
56. Lan HY, Paterson DJ, Atkins RC (1991): Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 40: 425-433.
57. Liu ZH, Chen SF, Zhou H et al. (2003): Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis. Nephrol Dial Transplant 18: 1526-1534. (Pubitemid 36939624)
58. Cockwell P, Savage CO (2000): Role of leukocytes in the immunopathogenesis of ANCA-associated glomerulonephritis. Nephron 85: 287-306. (Pubitemid 30665857)
59. Atkins RC, Nicolic-Paterson DJ, Song Q, Lan HY (1996): Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 7: 2271-2278.
60. Suzuki S, Gejyo F, Kuroda T et al. (1998): Effects of a novel elastase inhibitor INO-5046, on nephrotoxic serum nephritis in rats. Kidney Int 53: 1201-1208. (Pubitemid 28316880)
61. Johnson RJ, Couser WG, Chi EY et al. (1987): New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 79: 1379-1387.
62. Cunningham M, Huang XR, Dowling J et al. (1999): Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol 10: 499-506.
63. Moeller MJ, Soofi A, Hartmann I et al. (2004): Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 15: 61-67. (Pubitemid 38020698)
64. Tipping PG, Holdsworth SR (2006): T cells in crescentic glomerulonephritis. J Am Soc Nephrol 17: 1253-1263.
65. Goumenos D, Tsomi K, Iatrou C et al. (1998): Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol Dial Transplant 13: 1668-1674.
66. Bariety J, Hill GS, Mandet C et al. (2003): Glomerular epithelial - mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis. Nephrol Dial Transplant 9: 1777-1784. (Pubitemid 37098548)
67. Savage CO (2001): ANCA-associated renal vasculitis. Kidney Int 60: 1614-1627.
68. Gluhovschi G, Velciov S, Potencz E et al. (2003): Vasculitis with rapid evolution and morphopathological particularities. The Third Congress of the Romanian Society of Nephrology, Cluj 1-4 may 2003. Nefrologia 8: 22.
69. Kurts C (2006): Dendritic cells: Not just another cell type in the kidney, but a complex immune sentinel network. Kidney Int 70: 412-414.
70. nd ed., vol.1, Oxford University Press 1998, pp. 403-440.
71. Neilson EG (2006): Mechanisms of disease: fibroblasts - a new look at an old problem. Nat Clin Pract Nephrol 2: 101-108. (Pubitemid 43355218)
72. Strutz F, Neilson EG (1994): The role of lymphocytes in the progression of interstitial disease. Kidney Int 45 (Suppl): S106-110.
73. nd ed., vol.2, Oxford University Press 1998, pp. 1113-1128.
74. Abbate M, Remuzzi G (1999): Proteinuria as a mediator of tubulointerstitial injury. Kidney Blood Press Res 22: 37-46.
75. Kriz W, LeHir M (2005): Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67: 404-419. (Pubitemid 40139832)
76. Rugo HS, O'Hanley P, Bishop AG et al. (1992): Local cytokine production in a murine model of Escherichia coli pyelonephritis. J Clin Invest 89: 1032-1039.
77. Choudhury D, Ahmed Z (2006): Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol 2: 2.
78. Esteve JB, Launay-Vacher V, Brocheriou I et al. (2005): Cox-2 inhibitors and acute interstitial nephritis: case report and review of the literature. Clin Nephrol 63: 385-389. (Pubitemid 40668233)
79. Henao J, Hisamuddin I, Nzerue CM et al. (2003): Celecoxib-induced acute interstitial nephritis. Am J Kidney Dis 41: 720-721.
80. Almansori M, Kovithavongs T, Qarni MU (2005): Cyclooxigenase-2 inhibitor-associated minimal change disease. Clin Nephrol 63: 381-384.
81. Alper AB, Meleg-Smith S, Krane NK (2002): Nephrotic syndrome and interstitial nephritis associated with celecoxib. Am J Kidney Dis 40: 1086-1090. (Pubitemid 35265490)
82. Wörnle M, Schmid H, Banas B et al. (2006): Novel role of Toll-like receptor 3 in hepatitis-associated membranoproliferative glomerulonephritis. Am J Pathol 168: 370-385. (Pubitemid 43271137)
83. Ren Y, Carretero OA, Garvin JL (2002): Role of mesangial cells and gap junctions in tubuloglomerular feedback. Kidney Int 62: 525-531 (Pubitemid 34779763)
84. Hara M, Honda K, Matsuya S et al. (1988): The juxtaglomerular apparatus in IgA nephropathy: An analysis of the transport and fate of IgA deposits at the glomerular hilus. Virchows Archiv 413: 431-433.
85. Hvala A, Kobenter T, Ferluga D (2000): Fingerprint and other organized deposits in lupus nephritis. Wien Klin Wochenschr 112: 711-715. (Pubitemid 30673842)
86. Silva FG, Eigenbrodt EH, Glass M, Taft E (1986): An ultrastructural study of the renal juxtaglomerular apparatus and extraglomerular mesangium in patients with systemic lupus erythematosus. Am J Kidney Dis 7: 47-57. (Pubitemid 16157419)
87. Hugo C, Shankland SJ, Bowen-Pope DF et al. (1997): Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. J Clin Invest 15: 786-794. (Pubitemid 27371695)
88. Haseley LA, Hugo C, Reidy MA, Johnson RJ (1999): Dissociation of mesangial cell migration and proliferation in experimental glomerulonephritis. Kidney Int 5: 964-972. (Pubitemid 29411723)
89. Gluhovschi C, Gluhovschi G, Potencz E et al. (2008) What is the significance of CD34 immunostaining in the extraglomerular mesangium? Virchows Archiv 453: 321-328.
90. th ed., Lippincott, Williams and Wilkins 2005, pp. 369-389.
91. Navar LG, Harrison-Bernard LM, Imig JD: Compartmentalization of intrarenal angiotensina II (Chap. 16). In: Ulfendahl HR, Aurell M (eds.). Postland Press, London 1998, pp. 193-208.
92. Navar LG (2004): The intrarenal renin-angiotensin system in hypertension. Nephrology Forum. Principal discutant L.G. Navar. Kidney Int 65: 1522-1532.
93. Guzic TJ, Hoch NE, Brown KA et al. (2007): Role of T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460. (Pubitemid 47529329)
94. Geiger H (2008): T-cells in angiotensin-II-induced vascular damage. Nephrol Dial Transplant 23: 1107-1108.
95. Wolf G, Ritz E (2005): Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 67: 799-812. (Pubitemid 41623305)
96. Ruiz-Ortega M, Esteban V, Rupérez M et al. (2006): Renal and vascular hypertension-induced inflammation role of angiotensin II. Curr Opin Nephrol Hypertens 15: 159-166. (Pubitemid 43755821)
97. Esteban V, Ruperez M, Vita JR et al. (2003): Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. Kidney Int 86 (Suppl): S33-38.
98. Tsuboi N, Yoshikai Y, Matsuo S et al. (2002): Roles of toll-like receptors in c-c chemokine production by renal tubular epithelial cells. J Immunology 169: 2026-2033. (Pubitemid 34857667)
99. Wolf G, Bohlender J, Bondeva T et al. (2006): Angiotensin II upregulate Toll-like receptor 4 on mesangial cells. J Am Soc Nephrol 17: 1585-1593. (Pubitemid 43794661)
100. Anders HJ, Banas B, Linde Y et al. (2003): Bacterial CpG-DNA aggravates immune complex glomerulonephritis: Role of TLR9 - mediates expression of chemokines and chemokine receptors. J Am Soc Nephrol 14: 317-326. (Pubitemid 36150855)
101. van den Dobbelsteen ME, Verhasselt V, Kaashoek JG et al. (1994): Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon gamma. Clin Exp Immunol 95: 173-180. (Pubitemid 24207122)
102. Schlondorf D, Nelson PJ, Lucknow B, Banas B (1997): Chemokines and renal diseases. Kidney Int 51: 610-617.
103. Sterzel RB, Schulze-Lohoff E, Marx M (1993): Cytokines and mesangial cells. Kidney Int 43 (Suppl 39): 526-529.
104. Yee J, Kuncio GS, Neilson EG (1991): Tubulointerstitial injury following glomerulonephritis. Semin Nephrol 11: 361-366.
105. Klahr S, Morrisey JJ (1998): The role of growth factors, cytokines and vasoactive compounds in obstructive nephropathy. Semin Nephrol 18: 622-632. (Pubitemid 28506734)
106. Gerritsma JS, van Kooten C, Gerritsen AF et al. (1998): Transforming growth factor beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int 53: 609-616.
107. Cockwell P, Calderwood JW, Brooks CJ et al. (2002): Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines. Nephrol Dial Transplant 17: 734-744.
108. Hooke DH, Hancock WW, Gee DC et al. (1984): Monoclonal antibody analysis of glomerular hypercellularity in human glomerulonephritis. Clin Nephrol 22: 163-168.
109. Krüger T, Benke D, Eitner F et al. (2004): Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol 15: 613-621.
110. Tipping PG, Holdsworth P (2003): T cells in glomerulonephritis. Springer Semin Immunopathol 24: 377-393
111. Crispe IN (2009): The liver as a lymphoid organ. Annu Rev Immunol 27: 147-163.